A Phase 2 clinical trial at City of Hope has shown that monotherapy with sotorasib results in anti-tumor activity and a favorable benefit-risk profile among heavily pretreated patients with advanced colorectal...

What started as lower abdominal pains in January 2021 that would strike suddenly, like labor pains, eventually escalated to unintended weight loss, loss of appetite, blood in the stool and...

March is National Colorectal Cancer Awareness Month. The disease remains the fourth most common type of cancer and the second deadliest. In 2022, more than 150,000 people across the United...

"Cuando un paciente oye la temida palabra que comienza con “c”, esta suele desencadenar una ansiedad aguda, y cuando se trata de cáncer de colon, los temores que se expresan espontáneamente...

Roughly 15-20% of people diagnosed with colorectal cancer (CRC), the third most common cancer diagnosed in both sexes in the U.S., excluding skin cancer, will have tumors with deficient mismatch...

CONTACT Zen Vuong 626-409-9367 zvuong@coh.org   This new, blood-based test successfully identifies individuals with lymph node metastasis associated with high-risk T1 colorectal cancer and potentially could help people with non-high-risk...

“When a patient hears the “c” word, it usually triggers acute anxiety — and when it’s colon cancer , the fears they spontaneously express are: Am I going to die? Will...

A targeted therapy for colorectal cancer and an immunotherapy drug for head and neck cancer are just some of the innovative treatments City of Hope doctors presented at this year’s...

CONTACT Zen Vuong 626-409-9367 zvuong@coh.org   Participants with advance non-small cell lung cancer and colorectal cancer experienced the greatest benefits in this first-in-human study.   DUARTE, Calif. — A phase...

The remarkable results of a new City of Hope study show that the natural botanical Andrographis paniculata, when given in conjunction with chemotherapy, may be a major breakthrough in...